UBS analyst AJ Rice reaffirmed a “Buy” rating on The Cigna Group (NYSE:CI) with a price target of $390. Rice shared his views after a recent investor event at the Evernorth Innovation Lab, which was ...

Cigna stock gets a Buy rating today. Strengths: dividends, valuation, revenue growth, net income & EPS, share price vs. moving average, capital & liquidity. Offsetting factors: price performance ...

On the analyst front, TD Cowen reiterated its Buy rating for Cigna with a price target of $380, citing positive impacts from the company's recent business sale. Cantor Fitzgerald raised its price ...

Therefore, the Zacks rating upgrade for Cigna basically reflects ... in higher or lower fair value for a stock, and institutional investors typically buy or sell it. Their bulk investment action ...

Therefore, the Zacks rating upgrade for Cigna basically reflects ... in higher or lower fair value for a stock, and institutional investors typically buy or sell it. Their transaction of large ...

Cigna (CI – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Lisa Gill from J.P. Morgan maintained a Buy rating on the stock and has a $435. ...

UBS maintains Cigna stock Buy rating with $390 target View all comments (0) 0 Latest comments Post Comment Guidelines Trade With A Regulated Broker Indices Commodities Bonds Stocks US 30 41,598.50 ...

On Friday, UBS analyst AJ Rice confirmed a Buy rating for Cigna (NYSE: CI) shares, maintaining the $390.00 price target.Rice provided insights following a recent investor event at the Evernorth ...